Life Science Leader Magazine Supplements

CRO Leadership Awards 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/818304

Contents of this Issue

Navigation

Page 39 of 45

CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M Company Profiles 2017 CRO LEADERSHIP AWARDS WINNERS 38 THE CRO LEADERSHIP AWARDS 2017 LIFESCIENCELEADER.COM SERVICES & CAPABILITIES: Clinical trial imple- mentation & management, patient recruitment, peri and postapproval studies, registries, & value demonstration studies. We focus on helping biopharmaceutical sponsors generate real-world evidence to obtain regulatory approval. THERAPEUTIC AREAS: oncology, cardiology/vas- cular, neurology, endocrinology. gastroenterology, immunology & inflammation, infectious diseases, pulmonary/respiratory, urology, dermatology, rheumatology, women's health DRUG LIFE CYCLE STAGES: Research & Development: Phase 2, Phase 3 "At UBC, we believe experience matters. Our tenured scientists and operational experts work closely together to address pharma's challenges. We deliver a comprehensive, integrated view of clinical product, patient, and population safety – beginning in clinical development and lasting through a product's full lifecycle. The quality of our services is rooted in a strong commitment to our clients. Together, we can help them reach their goals while making medicines safer and more accessible to patients." PATRICK LINDSAY President CATEGORIES WON: UBC Blue Bell, Pennsylvania www.ubc.com Phone: 314-684-5112 Contact: Christine Portell Email: cportell@express-scripts.com Key locations: Blue Bell, PA; St. Louis, MO; London, England; Geneva, Switzerland; Memphis, TN; Kansas City, MO; McLean, VA; Montreal, Canada INDIVIDUAL ATTRIBUTE AWARDS: data quality, meeting overall project timelines, offered innova- tive solutions, responsiveness SERVICES & CAPABILITIES: Phase I-II, healthy normal volunteers, special populations, POC, adapt. design, FIH, SAD/MAD, bioavailability & bioequivalence, PK/ PD, dose ranging, food effect, QT/QTc, biosimilars, human abuse liability/substance abuse THERAPEUTIC AREAS: cardiovascular, CNS, cognitive testing, diabetes, electroencephalography, elderly, gastrointestinal, hematology, hepatitis, methadone/ buprenorphine, metabolic disorders, obesity, oph- thalmology, pain & inflammation, psychiatry, post- menopausal women, pulmonary, sleep disorders, substance abuse, women's health, others upon request DRUG LIFE CYCLE STAGES: Research & Development: Clinical, Phase 1 Phase 2 MAIN SERVICE AREAS: Full Service Clinical "To be recognized by industry leaders for excel- lence in all five award categories is truly an honor for Vince & Associates and our dedicated employees. Our team strives to provide innovative and customized early phase drug development solutions to our clients, adapting as the needs of the industry evolve. I am so proud of our team's accomplishments." BRADLEY VINCE, D.O. CEO & Medical Director CATEGORIES WON: Vince & Associates Clinical Research Overland Park, Kansas www.vinceandassociates.com Phone: 913-696-1601 Contact: Julie-Ann Cabana Email: jcabana@vinceandassociates.com Key locations: Overland Park, KS INDIVIDUAL ATTRIBUTE AWARDS: data quality, meeting overall project timelines, offered innovative solutions, operational excellence, responsiveness, tech- nology for real-time access to data SERVICES & CAPABILITIES: Worldwide Clinical Trials is one of the world's leading, full-service contract research organizations. We deliver fully integrated clin- ical development and bioanalytical services, extend- ing from first-in-human through phase IV studies. THERAPEUTIC AREAS: We help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular dis- eases, immune-mediated inflammatory disorders (IMID), & rare diseases. DRUG LIFE CYCLE STAGES: Research & Development: Clinical, Phase 1, Phase 2, Phase 3 MAIN SERVICE AREAS: Full Service Clinical "Each and every day, we put our customers first and are dedicated to collaborating with them to help them achieve their goals. We're thrilled to be consistently recognized in this way by our customers who participate in the survey -- this is the 4th year in a row that we've been honored in Life Science Leader's 2017 CRO Leadership Awards. This truly reflects the Worldwide team's integrity and commitment to quality." PETER BENTON President & COO CATEGORIES WON: Worldwide Clinical Trials Morrisville, North Carolina www.worldwide.com Phone: 919-674-2900 Contact: Bill Hirschman Email: william.hirschman@worldwide.com Key locations: North America, South America, Europe, Russia, Asia INDIVIDUAL ATTRIBUTE AWARDS: data quality, meeting overall project timelines, offered innovative solutions, operational excellence, responsiveness, tech- nology for real-time access to data

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2017